Particle.news

Download on the App Store

Oasis’ Bonehead Pauses Live ’25 Tour for Prostate Cancer Treatment

The founding guitarist reports good progress on treatment, with a planned return for the South American leg in November.

Overview

  • Paul “Bonehead” Arthurs disclosed on Instagram that he was diagnosed with prostate cancer earlier this year.
  • He will miss the upcoming shows in Seoul, Tokyo, Melbourne and Sydney during a planned break for the next phase of care.
  • Arthurs says he feels well and aims to rejoin the tour in November, with South American dates due to start on Nov. 15 in Buenos Aires.
  • Oasis reshared his statement and offered support, saying they expect to see him back on stage in South America.
  • No fill‑in has been announced for the affected dates; Arthurs previously received the all‑clear after tonsil cancer in 2022.